In conclusion, adding sitagliptin to insulin reduced HbA1c level by 0.9% without weight gain or increase in hypoglycemia, and improved treatment satisfaction in Japanese patients with suboptimally controlled T2DM. Here, INS is linked to Hypoglycemia.